Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02963090
Title Pembrolizumab vs Topotecan in Patients With Small Cell Lung Cancer
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Alliance Foundation Trials, LLC.
Indications

lung small cell carcinoma

Therapies

Pembrolizumab + Topotecan

Pembrolizumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.